News
India's Glenmark Pharmaceuticals said on Thursday its innovation arm, Ichnos Glenmark Innovation (IGI), and AbbVie have ...
Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...
Lawmakers bet millions on pharma stocks as Trump targets industry Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.
As North America CEO, Richard will advance Sun Pharma's diverse portfolio of innovative medicines, generics and over-the-counter products in both the U.S. and Canada. With a background spanning ...
In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management.
TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...
The impact of pharmaceutical roundtripping on the trade balance is both too big to continue and too big to ignore. Time for some real changes.
TME Pharma Provides Results of Final Exercise of Warrants Z 1,948 Warrants Z were exercised resulting in the issuance of 2,435 new ordinary shares Regulatory News: TME Pharma N.V. (Euronext Growth ...
October Pharma Annual stock financials by MarketWatch. View the latest OCPH financial statements, income statements and financial ratios.
TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...
TME Pharma Announces Successful Next Step in Its NOX-E36 Ophthalmology Strategy With Signature of Option Framework Agreement With Singapore Eye Research Institute (SERI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results